Clinical Trials Logo

Clinical Trial Summary

Background: Patients who survive severe brain injury may develop chronic disorders of consciousness (DoC). Treating these patients to improve recovery is extremely challenging because of scarce and inefficient therapeutical options. Among pharmacological treatments, apomorphine, a potent direct dopamine agonist, has exhibited promising behavioral effects, but its true efficacy and its mechanism remains unknown. This randomized controlled study aims to verify the effects of apomorphine subcutaneous infusion in patients with disorders of consciousness and investigate the neural networks targeted by this treatment. Methods/design: The double-blind randomized controlled trial will include 48 patients: 24 patients will be randomly assigned to the apomorphine and 24 to the placebo group. Investigators and the patients will be unaware of the nature of the treatment rendered. Primary outcome will be determined as behavioral response to treatment as measured by changes of diagnosis using the Coma Recovery Scale - Revised (CRS-R), while secondary outcome measures will include the Nociception Coma Scale - Revised (NCS-R), Disability Rating Scale (DRS), Wessex Head Injury Matrix (WHIM), circadian rhythm using actimetry, electroencephalography (EEG), positron emission tomography (PET) and functional magnetic resonance imaging (fMRI). The Glasgow Outcome Scale - Extended (GOS-E) and a phone-adapted version of the CRS-R will be used for long-term follow-up. Statistical analyses will focus on the detection of changes induced by apomorphine treatment at the individual level (comparing data before and after treatment) and at the group level (comparing responders with non-responders). Response to treatment will be measured at four different levels: 1. behavioral response (CRS-R, NCS-R, DRS, WHIM, GOS-E, phone CRS-R), 2. brain metabolism (PET), 3. network connectivity (resting-state fMRI, clinical EEG and high-density EEG) and 4. Circadian rhythm changes (actimetry, body temperature, 24h-EEG). Discussion: Apomorphine is a promising and safe strategy for the treatment of DoC but efficacy, profile of the responding population and underlying mechanism remain to be determined. This trial will provide unprecedented data that will allow to investigate the response to apomorphine using multimodal methods and shed new light on the brain networks targeted by this drug in terms of behavioral response, functional connectivity and metabolism.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05213169
Study type Interventional
Source University of Liege
Contact Emilie Szymkowicz, MSc.
Phone +32492319947
Status Recruiting
Phase Phase 2/Phase 3
Start date June 18, 2021
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Recruiting NCT05285124 - HD-tDCS Combined With Circadian Rhythm Reconstruction and Micro Expression Changes on Consciousness Recovery in Patients With Chronic Disturbance of Consciousness N/A
Not yet recruiting NCT05479032 - Amantadine for Neuroenhancement in Acute Patients Study Phase 2
Recruiting NCT05219331 - Hydrocephalus Treatment on Persistent Disorder of Consciousness N/A
Completed NCT03114397 - Long-term Effect of tDCS in Patients With Disorders of Consciousness N/A
Active, not recruiting NCT03623828 - Treating Severe Brain-injured Patients With Apomorphine Phase 2
Completed NCT04035655 - Sub-study of the NEURODOC Project : Neurophysiological Evaluation of a Routine Care Open Label tDCS Session N/A
Recruiting NCT03826407 - Development of a Point of Care System for Automated Coma Prognosis
Recruiting NCT03576248 - CONsciousness Transcranial Electric STimulation N/A
Recruiting NCT03611166 - Proteomics for Chronic Disorder of Consciousness
Recruiting NCT05382260 - Personal Music for Disorders of Consciousness N/A
Recruiting NCT05536921 - Eye Tracking Technology in the Diagnosis of Neurological Patients
Recruiting NCT05343507 - Ketamine to Treat Patients With Post-comatose Disorders of Consciousness Phase 2/Phase 3
Completed NCT02647996 - Functional Connectivity Measurement After Severe Traumatic Brain Injury
Recruiting NCT04530968 - Metabolic Abnormalities and Intestinal Microecology in Patients With Chronic Disorders of Consciousness
Recruiting NCT05640544 - Gamma Entrainment Improve the Recovery of Awareness N/A
Recruiting NCT04495192 - Predictors of Better Outcomes After Severe Acquired Brain Injuries
Recruiting NCT04921683 - The Use of LIFUP in Chronic Disorders of Consciousness N/A
Recruiting NCT04445649 - Prognostic Factors to Regain Consciousness
Recruiting NCT04442971 - Effectiveness of Music Therapy on Level of Consciousness N/A